{"id":65870,"date":"2021-04-19T23:41:18","date_gmt":"2021-04-19T21:41:18","guid":{"rendered":"https:\/\/www.csregypt.com\/?p=65870"},"modified":"2021-04-19T23:41:18","modified_gmt":"2021-04-19T21:41:18","slug":"sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent","status":"publish","type":"post","link":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/","title":{"rendered":"Sanofi Egypt first in Africa to get approval for registering Dupixent"},"content":{"rendered":"

Sanofi Egypt<\/a> is the first company in Africa to obtain approval for registering Dupixent as treatment for atopic dermatitis and severe uncontrolled asthma.<\/p>\n

In a press release on Monday, Sanofi Egypt<\/a> said Dupixent has been included on Egypt’s list of accredited medicine.<\/p>\n

Patients at the age of 12 and more can use Dupixent.<\/p>\n

Dr Ahmed Hegazy, the General Manager Egypt Sanofi Genzyme,<\/strong> said \u201cthis approval represents a new hope for patients suffering atopic dermatitis and severe uncontrolled asthma.\u201d<\/p>\n

He noted that atopic dermatitis patients are not only suffering from the disease, but also from its impact on their social and professional life.<\/p>\n

He added that patients of sever uncontrolled asthma also suffer from difficulties in breathing that threat their lives so that they cannot survive a normal life. Patients cannot be committed to regularly attend classes, go to work or participate in social activities.<\/p>\n

\n

\n

<\/h2>\n

\n

\n","protected":false},"excerpt":{"rendered":"

Sanofi Egypt is the first company in Africa to obtain approval for registering Dupixent as treatment for atopic dermatitis and severe uncontrolled asthma. In a press release on Monday, Sanofi Egypt said Dupixent has been included on Egypt’s list of accredited medicine. Patients at the age of 12 and more can use Dupixent. Dr Ahmed […]<\/p>\n","protected":false},"author":410,"featured_media":65871,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6262,6031,984],"tags":[10375,10374],"yoast_head":"\nSanofi Egypt first in Africa to get approval for registering Dupixent - Csr Egypt<\/title>\n<meta name=\"description\" content=\"Sanofi Egypt is the first in Africa to obtain approval for registering Dupixent as treatment for atopic dermatitis, severe uncontrolled asthma.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sanofi Egypt first in Africa to get approval for registering Dupixent - Csr Egypt\" \/>\n<meta property=\"og:description\" content=\"Sanofi Egypt is the first in Africa to obtain approval for registering Dupixent as treatment for atopic dermatitis, severe uncontrolled asthma.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/\" \/>\n<meta property=\"og:site_name\" content=\"Csr Egypt\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/csregypt\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-19T21:41:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"611\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Marwa Zein\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@egyptcsrforum\" \/>\n<meta name=\"twitter:site\" content=\"@egyptcsrforum\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marwa Zein\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/\"},\"author\":{\"name\":\"Marwa Zein\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec\"},\"headline\":\"Sanofi Egypt first in Africa to get approval for registering Dupixent\",\"datePublished\":\"2021-04-19T21:41:18+00:00\",\"dateModified\":\"2021-04-19T21:41:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/\"},\"wordCount\":155,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/csregypt.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg\",\"keywords\":[\"Dupixent\",\"Sanofi Egypt\"],\"articleSection\":[\"Egypt\",\"health\",\"news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/\",\"url\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/\",\"name\":\"Sanofi Egypt first in Africa to get approval for registering Dupixent - Csr Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/csregypt.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg\",\"datePublished\":\"2021-04-19T21:41:18+00:00\",\"dateModified\":\"2021-04-19T21:41:18+00:00\",\"description\":\"Sanofi Egypt is the first in Africa to obtain approval for registering Dupixent as treatment for atopic dermatitis, severe uncontrolled asthma.\",\"breadcrumb\":{\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#primaryimage\",\"url\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg\",\"contentUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg\",\"width\":1280,\"height\":611,\"caption\":\"Sanofi Egypt first in Africa to get approval for registering Dupixent\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/csregypt.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sanofi Egypt first in Africa to get approval for registering Dupixent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/csregypt.com\/#website\",\"url\":\"https:\/\/csregypt.com\/\",\"name\":\"\u0633\u064a \u0625\u0633 \u0622\u0631 \u0645\u0635\u0631\",\"description\":\"The first portal for CSR in Egypt and Middle East\",\"publisher\":{\"@id\":\"https:\/\/csregypt.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/csregypt.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/csregypt.com\/#organization\",\"name\":\"CSR\",\"url\":\"https:\/\/csregypt.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png\",\"contentUrl\":\"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png\",\"width\":1080,\"height\":1080,\"caption\":\"CSR\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/csregypt\/\",\"https:\/\/x.com\/egyptcsrforum\",\"https:\/\/www.instagram.com\/csr.egypt\/\",\"https:\/\/www.linkedin.com\/in\/csr-egypt-43381ab5\/\",\"https:\/\/www.pinterest.com.au\/csregypt\/\",\"https:\/\/www.youtube.com\/channel\/UCh21PZpnBj2yjj2PeclXz1g\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec\",\"name\":\"Marwa Zein\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g\",\"caption\":\"Marwa Zein\"},\"sameAs\":[\"http:\/\/marwazein1982@gmail.com\"],\"url\":\"https:\/\/csregypt.com\/en\/author\/marwa-zein\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sanofi Egypt first in Africa to get approval for registering Dupixent - Csr Egypt","description":"Sanofi Egypt is the first in Africa to obtain approval for registering Dupixent as treatment for atopic dermatitis, severe uncontrolled asthma.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/","og_locale":"en_US","og_type":"article","og_title":"Sanofi Egypt first in Africa to get approval for registering Dupixent - Csr Egypt","og_description":"Sanofi Egypt is the first in Africa to obtain approval for registering Dupixent as treatment for atopic dermatitis, severe uncontrolled asthma.","og_url":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/","og_site_name":"Csr Egypt","article_publisher":"https:\/\/www.facebook.com\/csregypt\/","article_published_time":"2021-04-19T21:41:18+00:00","og_image":[{"width":1280,"height":611,"url":"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg","type":"image\/jpeg"}],"author":"Marwa Zein","twitter_card":"summary_large_image","twitter_creator":"@egyptcsrforum","twitter_site":"@egyptcsrforum","twitter_misc":{"Written by":"Marwa Zein","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#article","isPartOf":{"@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/"},"author":{"name":"Marwa Zein","@id":"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec"},"headline":"Sanofi Egypt first in Africa to get approval for registering Dupixent","datePublished":"2021-04-19T21:41:18+00:00","dateModified":"2021-04-19T21:41:18+00:00","mainEntityOfPage":{"@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/"},"wordCount":155,"commentCount":0,"publisher":{"@id":"https:\/\/csregypt.com\/#organization"},"image":{"@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#primaryimage"},"thumbnailUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg","keywords":["Dupixent","Sanofi Egypt"],"articleSection":["Egypt","health","news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/","url":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/","name":"Sanofi Egypt first in Africa to get approval for registering Dupixent - Csr Egypt","isPartOf":{"@id":"https:\/\/csregypt.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#primaryimage"},"image":{"@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#primaryimage"},"thumbnailUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg","datePublished":"2021-04-19T21:41:18+00:00","dateModified":"2021-04-19T21:41:18+00:00","description":"Sanofi Egypt is the first in Africa to obtain approval for registering Dupixent as treatment for atopic dermatitis, severe uncontrolled asthma.","breadcrumb":{"@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#primaryimage","url":"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg","contentUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg","width":1280,"height":611,"caption":"Sanofi Egypt first in Africa to get approval for registering Dupixent"},{"@type":"BreadcrumbList","@id":"https:\/\/csregypt.com\/en\/sanofi-egypt-first-in-africa-to-get-approval-for-registering-dupixent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/csregypt.com\/"},{"@type":"ListItem","position":2,"name":"Sanofi Egypt first in Africa to get approval for registering Dupixent"}]},{"@type":"WebSite","@id":"https:\/\/csregypt.com\/#website","url":"https:\/\/csregypt.com\/","name":"\u0633\u064a \u0625\u0633 \u0622\u0631 \u0645\u0635\u0631","description":"The first portal for CSR in Egypt and Middle East","publisher":{"@id":"https:\/\/csregypt.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/csregypt.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/csregypt.com\/#organization","name":"CSR","url":"https:\/\/csregypt.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png","contentUrl":"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png","width":1080,"height":1080,"caption":"CSR"},"image":{"@id":"https:\/\/csregypt.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/csregypt\/","https:\/\/x.com\/egyptcsrforum","https:\/\/www.instagram.com\/csr.egypt\/","https:\/\/www.linkedin.com\/in\/csr-egypt-43381ab5\/","https:\/\/www.pinterest.com.au\/csregypt\/","https:\/\/www.youtube.com\/channel\/UCh21PZpnBj2yjj2PeclXz1g"]},{"@type":"Person","@id":"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec","name":"Marwa Zein","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g","caption":"Marwa Zein"},"sameAs":["http:\/\/marwazein1982@gmail.com"],"url":"https:\/\/csregypt.com\/en\/author\/marwa-zein\/"}]}},"jetpack_featured_media_url":"https:\/\/csregypt.com\/wp-content\/uploads\/2021\/04\/a9a68993-b6ee-4574-92ca-e4451c0c93bb.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/65870"}],"collection":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/users\/410"}],"replies":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/comments?post=65870"}],"version-history":[{"count":1,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/65870\/revisions"}],"predecessor-version":[{"id":65873,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/65870\/revisions\/65873"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/media\/65871"}],"wp:attachment":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/media?parent=65870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/categories?post=65870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/tags?post=65870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}